Overview
- Legal name
- QUANTABIO LLC
- Registered location
- BEVERLY, MA, USA
- Website
- Company website ↗
- Primary NAICS
- 325413 — In-Vitro Diagnostic Substance Manufacturing
- Latest award activity
- Mar 26, 2025
Read company summary
QUANTABIO LLC is associated with UEI YEF7JWZE6E38 and CAGE 9D1G1 in public federal records. AcornBids currently links 1 prime award totaling $243.6K in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Surgical Appliance and Supplies Manufacturing. These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 325413 (In-Vitro Diagnostic Substance Manufacturing). Its public SAM.gov registration lists BEVERLY, MA, USA.
At a glance
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Sep 27, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- QUANTABIO LLC
- UEI
- YEF7JWZE6E38
- CAGE
- 9D1G1
- Registered address
- 100 CUMMINGS CTR, BEVERLY, MA, 01915, USA
- Registration status
- Active
- Primary NAICS
- 325413 — In-Vitro Diagnostic Substance Manufacturing
- SAM activation
- Jul 24, 2026
- Initial registration
- Aug 31, 2022
- Entity start
- Jul 22, 2020
- SAM updated
- Jul 24, 2026
- Registration expires
- Jul 9, 2027
- Fiscal year end
- Dec 31
- Place of incorporation
- DE, USA
Federal award analysis
Net transaction obligations by federal fiscal period.
Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| 75P00224P00084BIOWATCH INVENTORY | Department of Health and Human Services | $243.6K | Dec 13, 2023 | May 31, 2026 |
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Jul 24, 2026 |
| Source loaded | Sep 26, 2026 |
| Initial registration | Aug 31, 2022 |
| Entity start | Jul 22, 2020 |
| Industry | Reported size status |
|---|---|
| 325413 — In-Vitro Diagnostic Substance Manufacturing | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| KIESHA CATHRIENNE RAGAS | Government business | Contact method not published | SAM registration | Not available |
| CURT OTTO | Alternate government business | Contact method not published | SAM registration | Not available |
| CURT OTTO | Electronic business | Contact method not published | SAM registration | Not available |
| KIESHA CATHRIENNE RAGAS | Alternate electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 325413 — In-Vitro Diagnostic Substance Manufacturing
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
No official subaward rows are loaded, so Acorn does not claim known teaming relationships.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit